Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Contract Pharmacal is recalling Major Extra Strength Acetaminophen tablets because a foreign prenatal tablet was found in a bottle.
Par Pharmaceutical is recalling 9,936 cartons of Frovatriptan Succinate Tablets, 2.5mg, because they are labeled with an incorrect expiration date.
PD-Rx Pharmaceuticals is recalling specific lots of ranitidine hydrochloride 150 mg tablets because a supplier reported potential NDMA levels above established limits.
Spectrum Laboratory Products is recalling Ranitidine Hydrochloride powder due to the presence of NDMA impurity. The product was distributed to pharmacies in 11 US states and internationally.
Ascend Laboratories is recalling 192 bottles of Olmesartan Medoxomil 20 mg tablets because they were released in error with an alternate API source before approval.
Teva Pharmaceuticals USA is recalling Desmopressin Acetate Tablets because bottles may be missing desiccant, a GMP deviation.
Macleods Pharma USA is recalling two lots of Pioglitazone and Metformin Hydrochloride tablets because they tested below the required potency levels.
Graviti Pharmaceuticals is recalling 29,056 bottles of 10 mg Atorvastatin Calcium Tablets because a 20 mg tablet was found in a bottle labeled for 10 mg tablets.
Teva Pharmaceuticals USA is recalling Desmopressin Acetate Tablets because bottles may be missing desiccant, a GMP deviation.
Ascend Laboratories is recalling Minocycline Hydrochloride Extended-Release Tablets due to low dissolution test results.
Unichem Pharmaceuticals is recalling Clonidine Hydrochloride tablets due to potential benzophenone migration from container labels. This is a precautionary measure.
Shandex Personal Care Manufacturing Inc. is recalling Walgreens Acne Cleansing Bar due to the presence of a visible metal contaminant.
Sildenafil 200 mg Troche is recalled for incorrect labeling and being compounded with expired components. Consumers in Texas should check their bottles and contact the manufacturer for instructions.
Pharmaceutical Associates Inc. is recalling Nystatin Oral Suspension because it failed potency testing at 12 months. Patients should stop using the product and consult their healthcare provider.
MPRX, Inc. dba Medical Park Pharmacy is recalling Lidocaine/Prilocaine/PE cream compounded with expired components and incorrect labeling.
MPRX, Inc. dba Medical Park Pharmacy is recalling DHEA/Pregnenol One 10.25 MG Capsules because they were compounded using expired components and have incorrect or missing lot and expiration dates.
MPRX, Inc. dba Medical Park Pharmacy is recalling Tadalafil 6 mg Capsules due to incorrect or missing lot and expiration dates and the use of expired components.
Macleods Pharma USA is recalling 10,680 bottles of Montelukast Sodium Chewable Tablets, 5 mg, because testing revealed low out-of-specification dissolution results in one lot.
MPRX, Inc. dba Medical Park Pharmacy is recalling T3/T4 SR 9 mcg/38 mcg capsules due to incorrect or missing lot and expiration dates and the use of expired components.
MPRX, Inc. is recalling Squaric Acid 0.1% Topical Solution due to incorrect or missing lot and expiration dates and the use of expired components.
MPRX, Inc. dba Medical Park Pharmacy is recalling Finasteride/Biotin 1 mg/50 mcg compounded using expired components and with incorrect or missing lot and expiration dates.
MPRX, Inc. dba Medical Park Pharmacy is recalling Liothyronine (T3) 92.5 MCG compounded with expired components due to incorrect or missing lot and expiration dates.
MPRX, Inc. dba Medical Park Pharmacy is recalling Tadalafil 20 mg Troche because the products were compounded using expired components and have incorrect or missing lot and expiration dates.
MPRX, Inc. is recalling Progesterone 200 mg Troche due to incorrect labeling and the use of expired components in compounding.
MPRX, Inc. dba Medical Park Pharmacy is recalling Sildenafil 80 mg capsules compounded with expired components and incorrect labeling.